These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29705091)

  • 21. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Kidney Function, Albuminuria, and Risks for All-cause and Cardiovascular Mortality in China: A Population-based Cohort Study.
    Wang J; Wang F; Liu S; Zhou M; Zhang L; Zhao M
    BMC Nephrol; 2017 Jun; 18(1):188. PubMed ID: 28592243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
    Chen S; Chen L; Jiang H
    Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
    Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.
    Penno G; Solini A; Zoppini G; Orsi E; Zerbini G; Trevisan R; Gruden G; Cavalot F; Laviola L; Morano S; Nicolucci A; Pugliese G;
    Diabetes Care; 2012 Nov; 35(11):2317-23. PubMed ID: 23093684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.
    Niu J; Zhang X; Li M; Wu S; Zheng R; Chen L; Huo Y; Xu M; Wang T; Zhao Z; Wang S; Lin H; Qin G; Yan L; Wan Q; Chen L; Shi L; Hu R; Tang X; Su Q; Yu X; Qin Y; Chen G; Gao Z; Wang G; Shen F; Luo Z; Chen Y; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Li Q; Mu Y; Zhao J; Bi Y; Ning G; Wang W; Lu J; Xu Y;
    Diabetes Metab; 2023 Mar; 49(2):101420. PubMed ID: 36640827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.
    Branch M; German C; Bertoni A; Yeboah J
    J Diabetes Complications; 2019 Jul; 33(7):468-472. PubMed ID: 31088728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
    Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
    Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus type 2 and chronic kidney disease.
    Roumeliotis A; Roumeliotis S; Panagoutsos S; Theodoridis M; Argyriou C; Tavridou A; Georgiadis GS
    Ren Fail; 2019 Nov; 41(1):131-138. PubMed ID: 30909780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes.
    Korbut AI; Klimontov VV; Vinogradov IV; Romanov VV
    World J Diabetes; 2019 Nov; 10(11):517-533. PubMed ID: 31798788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
    Pilemann-Lyberg S; Hansen TW; Tofte N; Winther SA; Theilade S; Ahluwalia TS; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of retinopathy and chronic kidney disease on long-term mortality in type 2 diabetic inpatients with normal urinary albumin or protein: a retrospective cohort study.
    Li YH; Sheu WH; Lee IT
    BMJ Open; 2018 Jul; 8(7):e021655. PubMed ID: 30049696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albuminuric and non-albuminuric patterns of chronic kidney disease in type 2 diabetes.
    Klimontov VV; Korbut AI
    Diabetes Metab Syndr; 2019; 13(1):474-479. PubMed ID: 30641747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-albuminuric chronic kidney disease in diabetes: A different approach?
    Borg R; Persson F
    Indian J Med Res; 2022; 156(4&5):685-686. PubMed ID: 36926787
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular risk factors and complications associated with albuminuria and impaired renal function in insulin-treated diabetes.
    Doggen K; Nobels F; Scheen AJ; Van Crombrugge P; Van Casteren V; Mathieu C
    J Diabetes Complications; 2013; 27(4):370-5. PubMed ID: 23537603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
    Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
    J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.